Literature DB >> 33673985

A comprehensive review on alginate-based delivery systems for the delivery of chemotherapeutic agent: Doxorubicin.

Jaya R Lakkakula1, Pratik Gujarathi2, Prachi Pansare2, Swastika Tripathi2.   

Abstract

Doxorubicin (DOX), an anthracycline drug, is widely used for the treatment of several cancers like osteosarcoma, cervical carcinoma, breast cancer, etc. DOX lacks target specificity; thereby it also affects normal cells thus resulting in several side-effects. A drug delivery system (DDS) can be used to deliver the drug in a controlled and sustained manner at a targeted site within the body. Various DDS like nanoemulsions, polymeric nanoparticles, and liposomes are used for loading DOX. Alginate, a polysaccharide is widely used for fabricating DDS due to its biodegradable and bio-compatible properties. Alginates, in combination with other biomaterials, have been extensively used as a novel drug delivery carrier for DOX. Alginate provides a platform for drug delivery in different forms like hydrogels, nanogels, nanoparticles, microparticles, graphene oxide systems, magnetic systems, etc. Herein, we briefly describe alginate in combination with other materials as a nanocarrier for targeted delivery of DOX for anti-cancer treatment.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alginate; Chemotherapy; Doxorubicin; Drug delivery

Mesh:

Substances:

Year:  2021        PMID: 33673985     DOI: 10.1016/j.carbpol.2021.117696

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  5 in total

Review 1.  Update on the Use of Nanocarriers and Drug Delivery Systems and Future Directions in Cervical Cancer.

Authors:  Loredana Maria Himiniuc; Bogdan Florin Toma; Razvan Popovici; Ana Maria Grigore; Alexandru Hamod; Constantin Volovat; Simona Volovat; Irina Nica; Decebal Vasincu; Maricel Agop; Mihaela Tirnovanu; Lacramioara Ochiuz; Anca Negura; Mihaela Grigore
Journal:  J Immunol Res       Date:  2022-05-04       Impact factor: 4.493

Review 2.  Polysaccharide-Drug Conjugates: A Tool for Enhanced Cancer Therapy.

Authors:  Neena Yadav; Arul Prakash Francis; Veeraraghavan Vishnu Priya; Shankargouda Patil; Shazia Mustaq; Sameer Saeed Khan; Khalid J Alzahrani; Hamsa Jameel Banjer; Surapaneni Krishna Mohan; Ullas Mony; Rukkumani Rajagopalan
Journal:  Polymers (Basel)       Date:  2022-02-27       Impact factor: 4.329

3.  Ultrathin, elastic, and self-adhesive nanofiber bio-tape: An intraoperative drug-loading module for ureteral stents with localized and controlled drug delivery properties for customized therapy.

Authors:  Liheng Gao; Mingxi Xu; Wenshuo Zhao; Ting Zou; Fujun Wang; Jun Da; Yiwei Wang; Lu Wang
Journal:  Bioact Mater       Date:  2022-03-22

4.  ROS triggered local delivery of stealth exosomes to tumors for enhanced chemo/photodynamic therapy.

Authors:  Zhuo Wan; Xueqi Gan; Ruiyan Mei; Jianbin Du; Wen Fan; Mengying Wei; Guodong Yang; Weiwei Qin; Zhuoli Zhu; Li Liu
Journal:  J Nanobiotechnology       Date:  2022-08-23       Impact factor: 9.429

Review 5.  Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review.

Authors:  Anandakrishnan Karthic; Arpita Roy; Jaya Lakkakula; Saad Alghamdi; Afnan Shakoori; Ahmad O Babalghith; Talha Bin Emran; Rohit Sharma; Clara Mariana Gonçalves Lima; Bonglee Kim; Moon Nyeo Park; Sher Zaman Safi; Ray Silva de Almeida; Henrique Douglas Melo Coutinho
Journal:  Front Cell Dev Biol       Date:  2022-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.